Global Nanomedicine Market Report to 2027 – by Nanomolecule Type, Nanoparticles Type, Application, Disease Indication and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type, By Application, By Disease Indication, By Region and Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Nanomedicine Market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242,655.19 million by 2027.

The market is driven by factors such as growing healthcare expenditures and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications.

Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the Global Nanomedicine Market in the forecast period.

Nanomedicines are considered very effective in treating chronic diseases such as cancer, dementia, and diabetes as they fuel the metabolism of medications in the body. They deliver the drugs at the target site in the right proportion. The market’s availability of nanomedical products such as DNA probes, nanosensors, and nanoparticle-based imaging agents is increasing the demand. However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the Global Nanomedicine Market in the forecast period.

The Global Nanomedicine Market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape. Based on application, the nanomedicine market is divided into drug delivery, vaccines, diagnostic imaging, regenerative medicine, and others.

Drug delivery applications dominated the market in 2021 and captured 30.23% of the overall market share. This segment is expected to maintain its dominance over the next five years. The rise in awareness about the benefits of nanomedicine in drug delivery applications and the increased prevalence of diseases drives the demand for nanomedicines for drug delivery applications.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023-2027

Objective of the Study:

• To analyze the historical growth and the market size of the Global Nanomedicine Market from 2017 to 2021.
• To estimate and forecast the market size of the Global Nanomedicine Market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the Global Nanomedicine Market is divided into nanomolecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.
• To identify drivers and challenges for the Global Nanomedicine Market.
• To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the Global Nanomedicine Market.
• To conduct pricing analysis for the Global Nanomedicine Market.
• To identify and analyze the profile of leading players operating in the Global Nanomedicine Market.

Companies Mentioned

• Pfizer Inc.
• Janssen Pharmaceuticals
• Sanofi S.A.
• Amgen Inc.
• Moderna, Inc.
• Novo Nordisk A/S
• Genentech, Inc
• Celgene Corporation
• Vifor Pharma Ltd.
• Teva Pharmaceutical Industries Ltd.

Report Scope:

In this report, the Global Nanomedicine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Nanomedicine Market, By Nanomolecule Type:

• Nanoparticles
• Nanoshells
• Nanodevices
• Nanotubes

Nanomedicine Market, By Nanoparticles Type:

• Polymer-based
• Lipid-based
• Nanocrystals
• Inorganic
• Others

Nanomedicine Market, By Application:

• Drug Delivery
• Vaccines
• Diagnostic Imaging
• Regenerative Medicine
• Others

Nanomedicine Market, By Disease Indication:

• Oncological Diseases
• Infectious Diseases
• Orthopedic Disorders
• Cardiovascular Diseases
• Others

Nanomedicine Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Denmark
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Malaysia
• Vietnam
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• Turkey
• Israel
• South Africa
• Saudi Arabia
• UAE
• Kuwait

For more information about this report visit https://www.researchandmarkets.com/r/9pmpfj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900